Expedition Therapeutics Raises $165M Series A Led by Sofinnova Investments and Novo Holdings

Deal Summary

Expedition Therapeutics, a San Francisco biotech developing therapies for inflammatory and respiratory diseases, raised $165M in a Series A round led by Sofinnova Investments and Novo Holdings. Additional investors include Forbion, Dawn Biopharma (KKR), Adage, Balyasny, Logos Capital, Sanofi Ventures and BVF Partners.